Carey, L. A.; Rugo, H. S.; Marcom, P. K.; Mayer, E. L.; Esteva, F. J.; Ma, C. X.; Liu, M. C.; Storniolo, A. M.; Rimawi, M. F.; Forero-Torres, A.; Wolff, A. C.; Hobday, T. J.; Ivanova, A.; Chiu, W.-K.; Ferraro, M.; Burrows, E.; Bernard, P. S.; Hoadley, K. A.; Perou, C. M.; Winer, E. P. (2012). TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer. Journal of Clinical Oncology, 30(21), 2615–2623.
doi:10.1200/JCO.2010.34.5579
url to share this paper:
An interview with Sci-Hub Founder Alexandra Elbakyan Who exactly should pay for academic research